论文部分内容阅读
胃癌是我国常见恶性肿瘤之一,尽管近几年来胃癌的发病率呈下降趋势,但其发病率和死亡率仍居恶性肿瘤之首。而化疗是失去手术机会的进展期胃癌患者主要的治疗手段。传统化疗药物的客观反应率仅为24%~40%。为了进一步改善胃癌患者预后,减少化疗的不良反应,近几年来有一些新药陆续
Gastric cancer is one of the common malignant tumors in our country. Although the incidence of gastric cancer is decreasing in recent years, the incidence and mortality of gastric cancer still ranks first in malignant tumors. Chemotherapy is the main treatment for patients with advanced gastric cancer who have lost their chance of surgery. The objective response rate of traditional chemotherapy drugs is only 24% to 40%. In order to further improve the prognosis of patients with gastric cancer and reduce the adverse reactions of chemotherapy, in recent years there are some new drugs one after another